 Accueil
|
Créer un blog
|
 Imprimer
|
 Au hasard
|
 Rechercher
|
 Chat
|
|
Jeux
|
 Manager
|
|
Accueil
|
Créer un blog
|
Imprimer
|
Au hasard
|
Rechercher
|
Chat
|
|
Jeux
|
Manager
|
| ||
| freemexy |
| ||
| Bumetanide belongs to a group of medicines called loop diuretics or
"water pills." Bumetanide is given to help treat fluid retention (edema)
and swelling that is caused by congestive heart failure, liver disease,
kidney disease, or other medical conditions. It works by acting on the
kidneys to increase the flow of urine .
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For bumetanide, the following should be considered:wisepoqder Bumetanide powder Allergies Tell your doctor if you have ever had any unusual or allergic reaction to bumetanide or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully. Pediatric Appropriate studies have not been performed on the relationship of age to the effects of bumetanide in the pediatric population. Safety and efficacy have not been established . Geriatric Appropriate studies performed to date have not demonstrated geriatrics-specific problems that would limit the usefulness of bumetanide in the elderly. However, elderly patients are more likely to have age-related liver, kidney, or heart problems, which may require an adjustment of dosage in patients receiving bumetanide .There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking bumetanide, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive. Using bumetanide with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.Using bumetanide with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Using bumetanide with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines. Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco. | ||
| 0 Commentaires | poster un commentaire | Lien Permanent |
| ||
| Monotherapy may be insufficient to lower intraocular pressure (IOP) for
some patients with glaucoma, but therapy with 2 agents may be
inconvenient and result in poor adherence. Yamamoto et al. reported
results of 2 phase 3 randomized controlled trials in which a fixed-dose
combination of 2% carteolol and 0.005% latanoprost, given as a single
therapeutic (termed OPC-1085EL), was evaluated for safety and efficacy.
OPC-1085EL was compared with carteolol and latanoprost administered as
monotherapies or as separate concomitant therapies. The authors found
that OPC-1085EL was well tolerated and reduced IOP more than the
monotherapy and comparably to the concomitant therapy.wisepoqder Carteolol powder
The trials were conducted at several centers in Japan and included patients with bilateral primary open-angle glaucoma or ocular hypertension. After a 4-week period with latanoprost or carteolol monotherapy, patients received 8 weeks of treatment with monotherapy, concomitant therapy, or OPC-1085EL applied daily in the morning. In study 1, the mean reduction in baseline-adjusted IOP for the 113 patients treated with OPC-1085EL (2.9 mm Hg) was significantly better than for the 116 patients treated with latanoprost monotherapy (1.6 mm Hg). In study 2, the mean reduction in baseline-adjusted IOP was significantly better for OPC-1085EL (n = 76; 3.5 mm Hg) than for carteolol (n = 76; 1.6 mm Hg). IOP reduction in the 37 patients who received carteolol and latanoprost concomitantly was similar to that in recipients of OPC-1085EL. In both studies, OPC-1085EL was tolerated well and associated with only mild adverse drug reactions. The authors concluded that OPC-1085EL is similar to concomitant therapy in terms of IOP-reducing efficacy but offers greater convenience. They noted that subsequent studies are needed to evaluate it for a longer duration, administered at other times of day, and in more diverse populations. | ||
| 0 Commentaires | poster un commentaire | Lien Permanent |
| Page 216 of 834 |
| Précédent | Suivant |